Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Legal Issues
Conor Medsystems comments on Netherlands court decision on Angiotech patent
February 14th, 2007
Conor Medsystems, Inc. (CONR) issued the following comment on the decision by District Court in The Hague which found Conor Medsystems' CoStar stent infringed a claim of the Dutch portion of European Patent (EP) 0 706 376 B1 to Angiotech Pharmaceuticals, Inc., and upheld the validity of that claim. "While we are disappointed with the Court's decision...we are pleased the Court invalidated the main claim of the patent and rejected Angiotech's request for a cross-border injunction and a ban on the use of our CE mark and clinical trial data," said Frank Litvack, MD, chairman and CEO of Conor. "We intend to appeal the decision and vigorously defend ourselves in these legal...
Source: Medical Patent Law Weekly (2007-02-14)
|
